{"url":"https://lda.senate.gov/api/v1/filings/2ef0e8cf-e342-49ce-bf9e-000f3d2482bd/","filing_uuid":"2ef0e8cf-e342-49ce-bf9e-000f3d2482bd","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2015,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2ef0e8cf-e342-49ce-bf9e-000f3d2482bd/print/","filing_document_content_type":"text/html","income":"75000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Richard J Tarplin","dt_posted":"2015-07-30T19:21:22.760000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"975 F Street NW Suite 500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":40032282,"url":"https://lda.senate.gov/api/v1/registrants/40032282/","house_registrant_id":39914,"name":"TARPLIN STRATEGIES LLC","description":"Government relations - lobbying/consulting","address_1":"975 F Street NW Suite 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MR. RICHARD J. TARPLIN","contact_telephone":"+1 202-441-1116","dt_updated":"2022-04-06T16:08:31.216695-04:00"},"client":{"id":188289,"url":"https://lda.senate.gov/api/v1/clients/188289/","client_id":51,"name":"AMERICAN MEDICAL ASSOCIATION","general_description":"American Medical Association represents physicians on related health care policy issues.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-01-16"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid physician payments, health insurance market reforms, delivery system reforms, health care financing options, physician antitrust and malpractice issues, health information technology, prevention and wellness issues, comparative effectiveness research.\nPublic Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid physician payments, health insurance market reforms, delivery system reforms, health care financing options, physician antitrust and malpractice issues, health information technology, prevention and wellness issues, comparative effectiveness research.\nQuality Measure Development\nElectronic Health Records - Meaningful Use Regulations\nPrescription Drug Diversion and Abuse\nMedicaid program - Parity for primary care physician services\nPublic Law 113-146, Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014, implementation of all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44990,"prefix":"mr","prefix_display":"MR.","first_name":"RICHARD","nickname":null,"middle_name":"JOSEPH","last_name":"TARPLIN","suffix":null,"suffix_display":null},"covered_position":"Assistant Secretary for Legislation/HHS; Principal Deputy Assistant Secretary for Legislation/HHS; Staff Director, Senate Subcommittee on Children and Families","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Program - Long term reform proposals for the Medicare physician payment system.\nMedicare Program - Regulatory and administrative issues with the Medicare physician formula.\nMedicare Program - Shared Savings/Accountable Care Organizations\nMedicare program - Value-based modifier\nMedicare program - Quality Reporting Programs\nMedicare program - New payment models/measuring quality performance\nMedicaid program - Parity for primary care physician services\nDiscussions concerning potential debt limit extension and deficit reduction legislation - physician payment issues.\nDiscussions with congressional staff on misvalued coding issues.\nMedicaid program - Parity for primary care physician services\nH.R.1470 and S. 810, the SGR Repeal and Medicare Provider Payment Modernization Act of 2015 - Medicare physician payment reform.\nPublic Law 114-10, the Medicare Access and CHIP Reauthorization Act - Medicare physician payment reform and CHIP extension.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44990,"prefix":"mr","prefix_display":"MR.","first_name":"RICHARD","nickname":null,"middle_name":"JOSEPH","last_name":"TARPLIN","suffix":null,"suffix_display":null},"covered_position":"Assistant Secretary for Legislation/HHS; Principal Deputy Assistant Secretary for Legislation/HHS; Staff Director, Senate Subcommittee on Children and Families","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Public Law 112-144, the Food and Drug Administration Safety and Innovation Act - implementation issues related to reauthorization of user fees for prescription drug, medical device, and biologics approval - Regulation of online pharmacies and prescription painkillers.\nPrescriber Education and CME Training\nFDA and HHS recommendations for rescheduling certain drugs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":44990,"prefix":"mr","prefix_display":"MR.","first_name":"RICHARD","nickname":null,"middle_name":"JOSEPH","last_name":"TARPLIN","suffix":null,"suffix_display":null},"covered_position":"Assistant Secretary for Legislation/HHS; Principal Deputy Assistant Secretary for Legislation/HHS; Staff Director, Senate Subcommittee on Children and Families","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}